首页> 外国专利> PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING EYE DISEASES, CONTAINING, AS ACTIVE INGREDIENT, FUSION PROTEIN IN WHICH TISSUE-PENETRATING PEPTIDE AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PREPARATION ARE FUSED

PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING EYE DISEASES, CONTAINING, AS ACTIVE INGREDIENT, FUSION PROTEIN IN WHICH TISSUE-PENETRATING PEPTIDE AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR PREPARATION ARE FUSED

机译:预防和治疗眼病的药物组合物,其中包含活性成分,组织穿透肽和抗血管内皮生长因子制备中的融合蛋白

摘要

FIELD: medicine.;SUBSTANCE: proposed group of inventions relates to medicine. Disclosed is a pharmaceutical composition for preventing and treating the eye disease caused by neovascularisation, containing a fusion protein in which the tissue penetrating peptide is fused with anti-VEGF. Disclosed method obtaining a fused protein, use thereof to produce a therapeutic agent for eyeball-induced eye diseases and a method of treating such a disease.;EFFECT: disclosed group of inventions provides effective treatment caused by neovascularisation of eye disease.;11 cl, 13 dwg, 7 tbl, 8 ex
机译:技术领域:药物:拟议的发明组涉及药物。公开了一种用于预防和治疗由新血管形成引起的眼部疾病的药物组合物,其包含融合蛋白,其中组织穿透肽与抗VEGF融合。公开的获得融合蛋白的方法,其用于生产眼球诱发的眼疾的治疗剂以及治疗这种疾病的方法。效果:公开的一组发明提供了由眼疾的新血管形成引起的有效治疗。 13桶,7桶,8桶

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号